radiofree.asia

June 10, 2021

To The Point with Dr. K. Anand Kumar, Managing Director, Indian Immunologicals Ltd

This post was originally published on Rajya Sabha TV.

←Student enrolment up by 11.4 per cent in higher education: AISHE report 2019-20

Vaccination of Olympic related staff kicks off in Ibaraki Prefecture→